By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Micell Technologies 

7516 Precision Drive

Raleigh  North Carolina  27617  U.S.A.
Phone: 919-313-2102 Fax: 919-313-2103


Medical Device

Company News
Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial Of MiStent In Japan 11/28/2016 9:15:02 AM
Durham's Micell Technologies Nabs $26 Million 11/21/2016 7:11:37 AM
Positive Five-Year Clinical Data From Micell Technologies' MiStent Presented At TCT 2016 10/31/2016 9:26:38 AM
Micell Technologies Completes Enrollment In OCT Study Designed To Evaluate Superior Performance Of MiStent SES Compared To Xience 3/22/2016 7:35:32 AM
Micell Technologies Highlights Data From Published Propensity Analysis Of MiStent SES And Market Standard Xience V Coronary Stent 2/25/2016 8:20:24 AM
Micell Technologies Announces Completion Of Enrollment In Mistent Randomized Trial Against Xience 12/10/2015 6:49:47 AM
Positive Four-Year Clinical Data From Micell Technologies' MiStent SES Presented At TCT 2015 10/13/2015 6:51:54 AM
Micell Technologies Announces Surgical Technologies Approved As MiStent SES Commercial Manufacturer For CE Mark Countries 8/20/2015 6:46:21 AM
Micell Technologies Announces First Patient Enrolled In Registration Trial Of Mistent SES In China 7/22/2015 8:02:47 AM
Micell Technologies Release: EuroPCR Late-Breaking Clinical Trials: MiStent SES Shows Clinical Superiority Over Market-Leader Xience V In Propensity Analysis At One And Three Years Post-Treatment 5/19/2015 6:29:55 AM